Respiratory

This study describes determinants affecting disease control and inhaled glucocorticosteroid therapy adherence for patients with asthma in western China.

A study found that chronic obstructive pulmonary disease (COPD) and asthma were not risk factors for ICU admission or death as a result of SARS-CoV-2 infection.

Johnson & Johnson, Novavax, release positive results from phase 3 trials on their respective coronavirus disease 2019 (COVID-19) vaccines; report indicates undercounted nursing home deaths in New York; experts push for improved mask practices.

This week, the top managed care news included FDA advising against changes to vaccine dose schedules; drop in mammography screenings during the first months of the pandemic; first anti-TIGIT therapy granted Breakthrough Therapy designation by the FDA.

The FDA warns against making any changes to the authorized dosing schedules of coronavirus disease 2019 (COVID-19) vaccines; joint health care venture, Haven, dissolves; Moderna announced it will increase production of its vaccine by 100 million doses for 2021.

Coronavirus disease 2019 (COVID-19) dominated 2020. This is a look back at how the pandemic evolved and progressed through the year, which closed with the arrival of vaccines, but also continued challenges.

One guideline focuses on managing severe asthma and the other begins with recommendations for mild intermittent asthma before increasing based on disease severity, noted Megan Althoff, MD, PhD, University of Colorado.

The top 5 most-read respiratory stories of 2020 on AJMC.com largely focused on the treatment options and risks associated with idiopathic pulmonary fibrosis (IPF) as well as how mental health and asthma are related.

When evaluating a patient’s response to a biologic for asthma, factors to consider include patient preference, safety, and symptoms, explained Nicola Hanania, MD, MS, pulmonary critical care physician and director, Airway Clinical Research Center, Baylor College of Medicine, Houston, Texas.

The Trump administration buys 100 million more doses of Pfizer's coronavirus disease 2019 (COVID-19) vaccine; the Department of Justice files a suit accusing Walmart of fueling the opioid crisis; 2020 set to become deadliest year in US history.

A look at some of our most-read news coverage of the coronavirus disease 2019 (COVID-19) pandemic.

After a daylong meeting, an FDA advisory panel agreed that the second vaccine in the United States to prevent coronavirus disease 2019 (COVID-19) should be put forward for use.

Stark realities exposed by the pandemic have led some to advocate for redirecting resources to have the most impact on vulnerable populations.

Updated guidelines help to address which patients are most appropriate for biologic therapy, noted Anne Reihman, MD, University of Colorado, Division of Pulmonary Sciences and Critical Care Medicine.

With leading health experts warning of a grim few months ahead as the pandemic continues to rage, and as a vaccine launch grows more imminent, this 3-part series explores the impact of existing health disparities on COVID-19 and some potential solutions.

A combination of stay-at-home orders and vape and smoke shop closures contributed to why many young adults and people under 21 years old quit or reduced vaping.

The United States reports record numbers of hospitalizations and deaths due to coronavirus disease 2019 (COVID-19); the CDC updates its quarantine recommendations; Moderna will soon start testing its COVID-19 vaccine in children.

Updating guidelines requires having sufficient information on the elements that are your focus, noted Dan Ouellette, MD, MS, FCCP, senior staff physician and director of the Respiratory Ward at Henry Ford Hospital.

The fall season was accompanied by an urgent warning from the CDC of an impending “twindemic” of coronavirus disease 2019 and influenza. Despite the warnings, Black women are not lining up for vaccinations.

The 2019/2020 GINA guidelines recommend formoterol to produce better long-term outcomes in patients, noted Megan Althoff, MD, PhD, second-year fellow, University of Colorado, Division of Pulmonary Sciences and Critical Care Medicine.

AstraZeneca announced that its vaccine against coronavirus disease 2019 (COVID-19) could be up to 90% effective; FDA grants emergency use authorization (EUA) for antibody cocktail used against COVID-19; spotlighting shortage of specialists to operate ventilators.

A study looked at how 4 types of interventions for children with asthma could impact expenditures and utilization among Medicaid programs.

Pfizer will submit an emergency use authorization for their coronavirus disease 2019 (COVID-19) vaccine; WHO panel recommends against remdesivir; CDC urges Americans to stay put during Thanksgiving.

A study looked at how 4 types of interventions for children with asthma could impact expenditures and utilization among Medicaid programs.

Artificial intelligence (AI) frees up time for clinicians, noted Anthony L. Loschner, MD, assistant professor and associate program director, Critical Care Fellowship Program, Virginia Tech Carilion School of Medicine.